This would mark a substantial improvement over the 14.9% weight loss observed with Wegovy in similar trials and the 20.9% achieved by Eli Lilly’s Zepbound. If confirmed, these results would position ...
Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) is a leading biopharmaceutical firm with a market cap of ...
As Chief Commercial Officer at Zoetis, Jamie Brannan will lead an evolved commercial organizational structure that will ...
STOCKHOLM, SE / ACCESSWIRE / November 11, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - Septem ...
Gaurav Mehta, who quit as the Chief Marketing Officer of Noise in March this year, has joined Lilly India as senior director ...